Concord, CA, United States of America

Jianmin Chen

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 7 EPO patents. Top assignee: Bayer Healthcare LLC. Active years: 2009-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianmin Chen. Retrieved from https://idiyas.com/inventor/jianmin-chen-wcek7re9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jianmin Chen

Introduction

Jianmin Chen is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII conjugates. With a total of 3 patents, his work has had a profound impact on medical science.

Latest Patents

Jianmin Chen's latest patents focus on Factor VIII muteins that are covalently bound to biocompatible polymers such as polyethylene glycol. These inventions retain FVIII procoagulant activity while improving pharmacokinetic properties. This innovative approach has the potential to enhance treatment options for patients requiring Factor VIII therapy.

Career Highlights

Jianmin Chen is currently employed at Bayer Healthcare LLC, where he continues to advance his research and development efforts. His expertise in biotechnology has positioned him as a key player in the industry, contributing to the advancement of therapeutic solutions.

Collaborations

Some of his notable coworkers include Clark Qun Pan and John E Murphy. Their collaborative efforts have further enriched the research environment at Bayer Healthcare LLC.

Conclusion

Jianmin Chen's contributions to the field of biotechnology, particularly through his patents on Factor VIII conjugates, demonstrate his commitment to innovation and improving patient care. His work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…